IP News

IP News

IPR Filings Hit Historic Low as Ex Parte Reexamination Eclipses Inter Partes Review for First Time Since AIA

Inter partes review (IPR) petitions filed at the U.S. Patent and Trademark Office have fallen to a level not seen since ...
IP News

Google Petitions U.S. Supreme Court Over USPTO’s ‘Settled Expectations’ IPR Denials

Google filed a petition for a writ of certiorari at the U.S. Supreme Court on April 27, 2026, challenging the U.S. Paten...
IP News

EPO and IEA Report Seven-Fold Rise in Battery Recycling Patents Over Past Decade

The European Patent Office (EPO) and the International Energy Agency (IEA) published a joint report on April 29, 2026, d...
IP News

UK High Court Sets $392 Million FRAND Lump Sum in Samsung v. ZTE Global SEP Dispute

Mr Justice Meade of the UK High Court (Patents Court) handed down judgment on 1 May 2026 in Samsung Electronics Co, Ltd ...
IP News

USPTO’s Internal Large Patent Family Review Program Faces Judicial Scrutiny Over Governance and Transparency

The transparency of internal USPTO patent examination programs is once again facing judicial scrutiny. As reported by IP...
IP News

USTR Designates Vietnam as Priority Foreign Country, Adds EU to Watch List in 2026 Special 301 Report

The USTR released its 2026 Special 301 Report on April 30, designating Vietnam as a Priority Foreign Country and adding ...
IP News

PTAB Pending Inventory Falls Below 2,000 for First Time in 20 Years as Director Squires Denies All IPR Petitions

The Patent Trial and Appeal Board's total pending inventory fell to 1,866 cases as of March 31, 2026, breaking below 2,0...
IP News

CureVac Sues Moderna Over mRNA Vaccine Patents, Adding to COVID-19 IP Litigation Wave

German biotech company CureVac SE, now a subsidiary of BioNTech, filed a patent infringement lawsuit against Moderna in ...
IP News

Judge Albright to Leave the Western District of Texas in August, Reshaping Patent Venue Calculus

U.S. District Judge Alan Albright has confirmed that he will leave the Western District of Texas at the end of August 20...
IP News

Federal Circuit Reinstates $177 Million Verdict in Teva v. Lilly CGRP Antibody Patent Case

The U.S. Court of Appeals for the Federal Circuit reinstated a $177 million jury verdict in Teva Pharmaceuticals Interna...